Accredited Investors’s Labcorp LH Stock Holding History

Accredited Investors’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.98M	Hold	10,650	–	–	0.13%	60
2026 Q1	$2.84M	Buy	+10,650	New	+$2.88M	0.15%	61

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Accredited Investors's LH Position: Q2 2026 in Review

Accredited Investors held its Labcorp (LH) position steady in Q2 2026 at 10,650 shares worth $2.98M. The position accounts for 0.13% of the portfolio, ranked #60.

Accredited Investors first reported a position in LH in Q1 2026 and has held it in 2 quarters since. 560 funds tracked by Wall St. Rank hold LH as of Q2 2026.

Accredited Investors held 10,650 shares of Labcorp worth $2.98M as of Q2 2026.
Accredited Investors left its Labcorp share count unchanged in Q2 2026.
Labcorp made up 0.13% of Accredited Investors's portfolio in Q2 2026, its #60 holding.
Accredited Investors first reported a position in Labcorp in Q1 2026 and has held it in 2 quarters since.
560 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Accredited Investors's 13F filing for Q2 2026, filed 21 Jul 2026.